Lura Health: Company Profile

Background

Overview

Lura Health is a pioneering health technology company specializing in non-invasive, continuous health monitoring through saliva-based diagnostics. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company aims to revolutionize chronic disease management by providing real-time health data via wearable sensors integrated into dental devices.

Mission and Vision

Lura Health's mission is to empower individuals with continuous, non-invasive health monitoring, enabling proactive management of chronic conditions and overall well-being. The company's vision is to integrate seamlessly into daily life, offering a discreet and comfortable method for individuals to monitor their health through saliva-based diagnostics.

Primary Area of Focus

The company focuses on developing wearable sensors that continuously monitor biomarkers in saliva, targeting chronic diseases such as heart disease, chronic kidney disease, diabetes, and tooth decay. By integrating these sensors into existing dental devices like retainers and aligners, Lura Health provides a non-invasive and user-friendly solution for health monitoring.

Industry Significance

Lura Health stands at the forefront of the health tech industry, addressing the growing demand for continuous, non-invasive health monitoring solutions. Its innovative approach to saliva-based diagnostics offers a promising alternative to traditional blood tests, potentially transforming chronic disease management and preventive healthcare.

Key Strategic Focus

Core Objectives

Continuous Health Monitoring: Develop wearable sensors that provide real-time, continuous monitoring of health biomarkers through saliva.

Chronic Disease Management: Offer non-invasive solutions for managing chronic conditions, enabling early detection and proactive intervention.

User-Friendly Integration: Integrate health monitoring sensors into everyday dental devices, ensuring comfort and ease of use for patients.

Specific Areas of Specialization

Salivary Diagnostics: Specialize in the development of sensors that detect various biomarkers in saliva, including glucose, electrolytes, and pH levels.

Wearable Health Technology: Focus on creating discreet, comfortable, and non-invasive wearable devices for continuous health monitoring.

Key Technologies Utilized

Salivary Biosensors: Employ advanced biosensor technology to detect and measure specific biomarkers in saliva.

Wireless Data Transmission: Utilize Bluetooth technology to transmit health data from the sensor to a smartphone application.

Integration with Dental Devices: Design sensors that can be embedded into existing dental hardware, such as retainers and aligners, for seamless user experience.

Primary Markets Targeted

Chronic Disease Management: Target individuals with chronic conditions like diabetes, heart disease, and chronic kidney disease who require continuous health monitoring.

Preventive Healthcare: Appeal to health-conscious individuals seeking proactive health monitoring solutions.

Dental Practices: Collaborate with dental professionals to integrate health monitoring into routine dental care.

Financials and Funding

Funding History

Lura Health has secured multiple funding rounds to support its innovative health monitoring solutions. Notable investors include the National Science Foundation, SOSV, MassChallenge, and SCO Group. The company has raised a total of approximately $2.5 million in funding.

Recent Funding Rounds

August 2025: Announced a strategic investment and business partnership with SCO Group to advance intraoral health monitoring.

Intended Utilization of Capital

The capital raised is intended to:

Product Development: Advance the development of wearable salivary diagnostic sensors.

Clinical Trials: Conduct clinical studies to validate the efficacy and safety of the sensors.

Market Expansion: Expand operations into international markets, particularly in Asia, through strategic partnerships.

Pipeline Development

Key Pipeline Candidates

Intraoral Salivary Sensors: Develop sensors integrated into dental devices to monitor biomarkers such as glucose, electrolytes, and pH levels.

Stages of Development

Prototype Development: Completed initial prototypes of the salivary sensors.

Clinical Studies: Conducting first-in-human clinical studies to assess sensor performance and safety.

Regulatory Approval: Seeking FDA clearance for the sensors, with plans for early 2027.

Target Conditions

Diabetes: Continuous glucose monitoring through saliva.

Chronic Kidney Disease: Monitoring electrolyte levels to manage kidney function.

Heart Disease: Assessing biomarkers related to cardiovascular health.

Tooth Decay: Detecting early signs of dental issues through salivary pH levels.

Anticipated Milestones

FDA Clearance: Expected in early 2027, enabling broader market adoption.

Market Launch: Planned introduction of the sensors in the U.S. and Asian markets post-clearance.

Technological Platform and Innovation

Proprietary Technologies

Salivary Biosensors: Develop proprietary sensors capable of detecting specific biomarkers in saliva.

Wireless Data Transmission: Implement secure Bluetooth communication protocols for data transfer to mobile devices.

Integration with Dental Devices: Design sensors that can be embedded into existing dental hardware, such as retainers and aligners.

Significant Scientific Methods

Electrochemical Sensing: Utilize electrochemical techniques for accurate detection of biomarkers in saliva.

Data Analytics: Employ advanced algorithms to analyze health data and provide actionable insights.

Leadership Team

Executive Profiles

Daniel Weinstein: Co-Founder and CEO. Holds a degree in biomedical engineering and has experience in electrochemical sensing. Led the development of the salivary biosensor technology and secured initial funding.

Noah Hill: Co-Founder and CTO. Holds a degree in computer science and specializes in embedded systems. Engineered the integration of sensors into dental devices and developed data transmission protocols.

Saam Bozorg: Co-Founder and Medical Director. Holds a Doctor of Dental Medicine (DMD) degree and provides clinical expertise. Ensured the clinical relevance and feasibility of the sensors within dental practices.

Recent Leadership Developments

August 2025: Announced a strategic partnership with SCO Group to advance intraoral health monitoring.

Market Overview and Competitor Profile

Market Insights and Dynamics

The wearable health monitoring market is experiencing significant growth driven by increased health awareness and demand for continuous health data. Saliva-based diagnostics are emerging as a non-invasive alternative to blood tests, offering advantages in patient comfort and compliance.

Competitor Analysis

Avance Innovations: Specializes in advanced medical devices with a focus on chronic disease management.

Orthomod: Develops biologic products and medical devices in the orthopedic sector.

Sensome: Provides remote monitoring technology for vascular medical devices.

HealthArc: Offers remote patient monitoring platforms for virtual healthcare delivery.

Strategic Collaborations and Partnerships

SCO Group: Partnered with Lura Health in August 2025 to integrate sensors into dental clinics across Asia, aiming to enhance preventive healthcare.

Operational Differentiators

Lura Health distinguishes itself through its non-invasive, saliva-based monitoring approach embedded in dental devices, providing continuous health data without discomfort. This unique positioning offers a patient-friendly alternative to traditional monitoring methods in the wearable health technology market.

Strategic Opportunities and Future Directions